CVS Health Aktie
| 76,12USD | 0,06USD | 0,08% |
WKN: 859034 / ISIN: US1266501006
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 300 000 | 300 000 | 300 000 | 300 000 | 300 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,97 | 1,08 | 1,19 | 1,24 | 1,34 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 60 008 | 65 682 | 67 858 | 68 645 | 74 714 |
| Summe Anlagevermögen | 180 488 | 170 583 | 189 872 | 192 177 | 186 350 |
| Summe Aktiva | 240 496 | 236 265 | 257 730 | 260 822 | 261 064 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 165 115 | 164 950 | 181 094 | 185 092 | 185 682 |
| Summe Eigenkapital | 75 381 | 71 315 | 76 636 | 75 730 | 75 382 |
| Summe Passiva | 240 496 | 236 265 | 257 730 | 260 822 | 261 064 |
Adresse
| 1 CVS Drive, 02895 Woonsocket | |
| Telefon | +1 (401) 765-1500 |
| Internet | http://www.cvshealth.com |
Management
|
Alecia A. DeCoudreaux
Independent Director |
|
Amy Compton-Phillips
Chief Medical Officer & Executive Vice President |
|
Anne M. Finucane
Independent Director |
|
Brian O. Newman
Chief Financial Officer & Executive Vice President |
|
Bryan Cook
Regional Director-Real Estate |
|
C. David Brown
Independent Director |
|
Charles Golden
SVP-Construction & Property Administration |
|
David A. Falkowski
Chief Compliance Officer & Executive VP |
|
David Berman
Director-Real Estate Metro NY |
|
Deborah LeClerc
Coordinator-Real Estate |
|
Douglas H. Shulman
Independent Director |
|
Fernando G. Aguirre
Independent Director |
|
Guy P. Sansone
Independent Director |
|
Heidi B. Capozzi
Chief People Officer & Executive Vice President |
|
Holly Jensen
Director-Real Estate & Executive Advisor |
|
J. David Joyner
Chairman, President & Chief Executive Officer |
|
J. Scott Kirby
Independent Director |
|
James D. Clark
Chief Accounting Officer, Senior VP & Controller |
|
Jason L. Monroe
Sales Manager |
|
Jeffrey R. Balser
Independent Director |
|
Jenice Tom
Director-Real Estate Market Research & Analytics |
|
Kristina V. Fink
Secretary, Chief Governance Officer & Senior VP |
|
Larry Webb
Director-Real Estate |
|
Laurence McGrath
Executive Vice President-Capital Markets |
|
Lawrence Michael Robbins
Independent Director |
|
Leslie V. Norwalk
Non-Independent Director |
|
Lucille Accetta
Chief Pharmacy Officer |
|
Madi Rajulapalli
Regional Medical Director-Medicare Case Management |
|
Matthew J. Leonard
EVP-Pharmaceutical Contracting & Purchasing |
|
Matthew Tamke
Director-OTC Health Solutions |
|
Melissa A. Schulman
Senior Vice President-Government & Public Affairs |
|
Michael F. Mahoney
Lead Independent Director |
|
Michael Kurimcak
Vice President-Real Estate |
|
Per G. H. Lofberg
Executive Vice President |
|
Prem S. Shah
Executive Vice President |
|
Robert Holtzman
Regional Real Estate Manager |
|
Roger N. Farah
Non-Independent Director |
|
Samrat S. Khichi
Chief Policy Officer, General Counsel & EVP |
|
Sheryl A. Burke
Chief Sustainability Officer & Senior VP |
|
Thomas S. Moffatt
Vice President & Senior Legal Counsel |
|
Tilak Mandadi
EVP, Chief Experience & Technology Officer |
|
Todd Galusha
Real Estate Advisor |
|
Tracy L. Smith
Treasurer & Senior Vice President |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.